Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Sobi and Menarini receive marketing authorization for SJIA drug in Australia

Swedish Orphan Biovitrum AB, or Sobi, a specialty pharmaceutical company, and A. Menarini Australia Pty Ltd have received marketing authorization for Kineret, indicated for the treatment of systemic juvenile idiopathic arthritis, or SJIA, in Australia.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Patterson Companies Q1 net income decreases

Patterson Companies, Inc., a distributor of dental, veterinary and rehabilitation supplies, has reported that net income for the first quarter ended August 1, 2015 was $29.70 million, or $0.30 per diluted share, compared to $50.29 million, or $0.50 per diluted share, for the same quarter ended July 26, 2014.

Published By MarketLine
29 Aug 2015
NewsWire
NewsWire

Cipla Q1 net profit increases

Cipla Limited, a biotechnology company, has reported that net profit after minority interest and share of profit of associates for the first quarter ended June 30, 2015 was INR6.51 billion, or INR8.07 per diluted share, compared to INR2.94 billion, or INR3.66 per diluted share, for the same quarter ended June 30, 2014.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

CASI Pharmaceuticals Q2 net loss increases

CASI Pharmaceuticals, Inc., a biopharmaceutical company, has reported that net loss for the second quarter ended June 30, 2015 was $2.09 million, or $0.06 loss per share, compared to a net loss of $1.62 million, or $0.06 loss per share, for the same quarter ended June 30, 2014.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

Zecotek signs agreements with ECM for 3D auto-stereoscopic display monitors

Zecotek Photonics Inc. has announced that its wholly owned subsidiary, Zecotek Display Systems Pte Ltd., has signed agreements with the Engineering Centre of the National Research Nuclear Center MEPhi, or ECM, and its business affiliate, Novilab Mobile LLC., to commercialize Zecotek's patented 3D auto-stereoscopic display monitors in Russia and countries of the Commonwealth of Independent States, or CIS.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

GHP Specialty Care Q2 income decreases

GHP Specialty Care AB has reported that income attributable to parent company's shareholders for the second quarter ended June 30, 2015 was SEK6.5 million, or SEK0.10 per share, compared to SEK7.4 million, or SEK0.11 per share, for the same quarter ended June 30, 2014.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

Onconova submits IND for myelodysplastic syndrome drug to FDA

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, has submitted an investigational new drug, or IND, application to the FDA for IV rigosertib as a treatment for higher-risk myelodysplastic syndromes, or HR-MDS, after failure of hypomethylating agent, or HMA, therapy.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

Aeolus Pharmaceuticals reports net loss for Q3

Aeolus Pharmaceuticals, Inc., a biotechnology company, has reported that net loss for the third quarter ended June 30, 2015 was $784,000, or $0.01 loss per share, compared to a net income of $1.58 million, or $0.01 per share, for the same quarter ended June 30, 2014.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

Veracyte appoints chief medical officer

Veracyte, Inc., a molecular diagnostics company, has appointed Neil Barth as the chief medical officer.

Published By MarketLine
28 Aug 2015
NewsWire
NewsWire

Seattle Genetics receives FDA approval for Hodgkin lymphoma drug

Seattle Genetics, Inc., a biotechnology company, has received the FDA approval for ADCETRIS, or brentuximab vedotin, for the treatment of patients with classical Hodgkin lymphoma, or HL, at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation, or auto-HSCT, consolidation.

Published By MarketLine
28 Aug 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.